stonks4u
Sign up free
ABSI logo

ABSI Absci Corporation

NASDAQ Global Select · Biotechnology · Healthcare

$9.18
-0.28 (-2.96%)

Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced …

Market Cap: $1.56Bwww.absci.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

110
110
Aug 11Aug 11

Quote

Day Range
$8.83 – $9.44
52-Week Range
$2.24 – $12.05
Volume
$2.23M
Market Cap
$1.56B
50-Day Avg
$8.74
200-Day Avg
$4.86
Prev Close
$9.46
Open
$9.43

Valuation & Ratios

P/E Ratio
-4.15
EPS
$-0.84
P/B Ratio
2.52
P/S Ratio
170.48
Debt/Equity
0.03
Current Ratio
6.57
Dividend Yield
+0.0%
Gross Margin
-319.4%

Returns & Efficiency

Return on Equity
-60.8%
Return on Assets
-53.3%
FCF Yield
-19.7%
EV/EBITDA
-4.48

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$2.80M$-115.18M$-0.84
2024$4.53M$-103.11M$-0.94
2023$5.72M$-110.57M$-1.20
2022$5.75M$-104.90M$-1.15
2021$4.78M$-100.96M$-1.11

Social Signal Score

61
5d
61
3 mentions
—
30d
61
3 mentions
—
60d
61
3 mentions
—
90d
61
3 mentions
—
news: 3

Earnings

Wed, Nov 11(in 3 months)

Consensus estimate $-0.15 per share

3of 7 quarters beat consensus

Typical surprise -5.3% (median, so one quarter with a near-zero estimate can't distort it)

  • Tue, Aug 11$-0.18 vs $-0.19beat
  • Thu, May 7$-0.19 vs $-0.20beat
  • Tue, Mar 24$-0.23 vs $-0.16miss
  • Wed, Nov 12$-0.20 vs $-0.19miss
  • Tue, Aug 12$-0.24 vs $-0.19miss
  • Tue, May 13$-0.21 vs $-0.23beat

Estimates and results for ABSI via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

ABSIhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (3)

  • Newsseekingalpha.com·3d ago·Positive

    Absci Corporation (ABSI) Q2 2026 Earnings Call Transcript Absci Corporation (ABSI) Q2 2026 Earnings Call Transcript

    View source ↗
  • Newsmarketbeat.com·3d ago·Negative

    Absci Q2 Earnings Call Highlights Absci NASDAQ: ABSI outlined progress in its clinical program for ABS-201, a prolactin receptor-targeting antibody being studied for pattern hair loss and planned for development in endometriosis, while reporting a larger cash balance following a June equity offering and strategic investment from Eli Lilly.

    View source ↗
  • News247wallst.com·4d ago·Positive

    The Biggest IPO of the Year Is Targeted in the Next 60 Days. Why One Unexpected Industry Could Rally Before Then (Hint: It’s Not Tech) Anthropic is preparing what could be the largest IPO of 2026, and it's telling investors the pitch goes well beyond chatbots. According to the Wall Street Journal, "Anthropic is targeting a public debut in September or early October, people familiar with its plans said." In those same meetings, the company told some investors that it... The Biggest IPO of the Yea

    View source ↗